GENE ONLINE|News &
Opinion
Blog

Kidney Disease
M&A acquisitionNovartis
Novartis Plans to Acquire Chinook Therapeutics in a Potential $3.5B Deal, Revolutionizing IgAN Treatment Landscape
2023-06-14
Partnerships siRNAKidney Disease
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
Funding Kidney Disease
In-Home Kidney Disease Management Company, Monogram, Raises $375 Million
2023-01-13
Trials & Approvals IgA Nephropathy
Vera Therapeutics Eyes Phase 3 For Kidney Disease Candidate Following Positive Data
2023-01-04
Trials & Approvals IgA Nephropathy
Everest’s Renal Drug Gets Placed On Fast Track For Approval In Taiwan And Korea
2022-11-28
Trials & Approvals RNAi
Alnylam Posts Positive Phase 2 Results for its RNAi Nephropathy Drug
2022-08-30
Trials & Approvals Kidney Disease
Ocelot’s Rare Kidney Disease Candidate Receives Orphan Drug Designation Going Into Phase 2 Trials
2022-08-23
Trials & Approvals Kidney Disease
Everest, Calliditas Win First Approval for Rare Kidney Disease Drug in Europe
2022-07-18
Licensing IONIS-FB-LRx
Roche Receives Rights to Ionis’ Antisense Kidney Disease Drug for $55 Million
2022-07-12
China Autoimmune
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
Deals Acute Kidney Injury
AM-Pharma Partners with Kyowa Kirin in $289m Deal for Kidney Drug
2021-09-09
Trials & Approvals FDA Approval
FDA Approves Cara & Vifor’s CKD-Associated Pruritus Injection
2021-08-26
Trials & Approvals Kidney Disease
Venglustat’s Phase 2/3 Trial Failure Pushes Sanofi to Drop Kidney Disease Program
2021-06-02
Trials & Approvals Kidney Disease
FDA Approves Second Lupus Nephritis Drug in Two Months
2021-01-25
M&A Kidney Disease
Chinook Therapeutics Completes Merger with Aduro BioTech Inc.
2020-10-05
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top